🇺🇸 FDA
Patent

US 9820991

Pharmaceutical composition comprising brinzolamide

granted A61KA61K31/542A61K47/02

Quick answer

US patent 9820991 (Pharmaceutical composition comprising brinzolamide) held by SENTISS PHARMA PRIVATE LIMITED expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SENTISS PHARMA PRIVATE LIMITED
Grant date
Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/542, A61K47/02, A61K47/183, A61K47/186